Brief: BD, Biocorp Sign Agreement To Bring Connectivity, Traceability To Self-Administered Injectable Drugs
Oct 18 (Reuters) - Becton Dickinson and Co BDX.N :
* BD, BIOCORP SIGN AGREEMENT TO BRING CONNECTIVITY,
TRACEABILITY
TO SELF-ADMINISTERED INJECTABLE DRUGS
Source text for Eikon: ID:nBw3BcZvfa
Further company coverage: BDX.N
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Becton Dickinson and Co
See all newsCorrected: BDx secures data center power contract from Indonesia's PLN
China's commerce ministry holds meeting with foreign pharmaceutical firms
Brief: Becton Dickinson Euro Finance S.À R.L Files For Euro-Denominated 600 Million 3.855% Notes Offering Due 2033 - SEC Filing
U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
Becton Dickinson raises 2026 profit forecast on drug delivery devices demand (updated)